Cargando…
Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer
Cyclin-dependent kinase (CDK) inhibitors represent a new form of cytotoxic chemotherapy. Advanced practitioners can read this article to find out about the science behind CDK inhibition, when CDKs are indicated, how to monitor for and manage side effects, as well as when and how to dose adjust.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003757/ https://www.ncbi.nlm.nih.gov/pubmed/29928547 |
| _version_ | 1783332405430452224 |
|---|---|
| author | Schwartzberg, Lee S. Greene, Heather R. |
| author_facet | Schwartzberg, Lee S. Greene, Heather R. |
| author_sort | Schwartzberg, Lee S. |
| collection | PubMed |
| description | Cyclin-dependent kinase (CDK) inhibitors represent a new form of cytotoxic chemotherapy. Advanced practitioners can read this article to find out about the science behind CDK inhibition, when CDKs are indicated, how to monitor for and manage side effects, as well as when and how to dose adjust. |
| format | Online Article Text |
| id | pubmed-6003757 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Harborside Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60037572018-06-20 Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer Schwartzberg, Lee S. Greene, Heather R. J Adv Pract Oncol Review Article Cyclin-dependent kinase (CDK) inhibitors represent a new form of cytotoxic chemotherapy. Advanced practitioners can read this article to find out about the science behind CDK inhibition, when CDKs are indicated, how to monitor for and manage side effects, as well as when and how to dose adjust. Harborside Press 2017-04 2017-04-01 /pmc/articles/PMC6003757/ /pubmed/29928547 Text en Copyright © 2017, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes. |
| spellingShingle | Review Article Schwartzberg, Lee S. Greene, Heather R. Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer |
| title | Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer |
| title_full | Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer |
| title_fullStr | Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer |
| title_full_unstemmed | Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer |
| title_short | Collaborative Management of Patients With Estrogen Receptor–Positive Breast Cancer |
| title_sort | collaborative management of patients with estrogen receptor–positive breast cancer |
| topic | Review Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003757/ https://www.ncbi.nlm.nih.gov/pubmed/29928547 |
| work_keys_str_mv | AT schwartzberglees collaborativemanagementofpatientswithestrogenreceptorpositivebreastcancer AT greeneheatherr collaborativemanagementofpatientswithestrogenreceptorpositivebreastcancer |